Cargando…
NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy
The last 10 years have revolutionized our basic understanding of nonalcoholic fatty liver disease and consequent liver cancer. It has become clear that several innate and adaptive immune cells play an important role in initiating, maintaining, or exacerbating nonalcoholic steatohepatitis (NASH)—a di...
Autores principales: | Pinter, Matthias, Pinato, David J., Ramadori, Pierluigi, Heikenwalder, Mathias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890137/ https://www.ncbi.nlm.nih.gov/pubmed/36166660 http://dx.doi.org/10.1158/1078-0432.CCR-21-1258 |
Ejemplares similares
-
Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022) -
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma
por: Manfredi, Giulia Francesca, et al.
Publicado: (2023) -
Platelets in chronic liver disease, from bench to bedside
por: Ramadori, Pierluigi, et al.
Publicado: (2019) -
Surveillance for Hepatocellular Carcinoma in Patients with NASH
por: Kolly, Philippe, et al.
Publicado: (2016) -
Immunotherapy in Hepatocellular Carcinoma
por: Fulgenzi, Claudia A. M., et al.
Publicado: (2021)